Skip to main content
♕ The Globe and Mail Trade Off
Canada's free stock market contest is live! Test your investing skills for a chance to win $5,000.Enter Now!Enter Now!
➜

Adtalem Global Education Inc(ATGE-N)
NYSE

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time
Day Low95.90
Day High99.72
Open:96.00
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.

TOP STORIES: Adtalem Global Education Inc

Select a category then submit the form to load news
StockStory
3 Value Stocks We Approach with Caution
ASAN
Tipranks
Covista Unveils Purpose at Scale Healthcare Growth Strategy
StockStory
3 of Wall Street’s Favorite Stocks We Steer Clear Of
ATGE
Motley Fool
Walker & Dunlop Stock Down 30% but Revenue Up 16%: Why This $6 Million Sale Stands Out
Motley Fool
Laureate Education Stock Up 70% as Fund Trims $9 Million Stake Amid $1.7 Billion Revenue Outlook
Motley Fool
Why This $14 Million Bet on Adtalem Global Stock Could Signal a Healthcare Education Pivot
Motley Fool
Fund Opens $7.8 Million Position in Farmer Mac Despite 20% S&P Underperformance
Zacks Investment Research
Stride Stock Gains 20% in a Month: Buy Now or Hold Tight?
Stride Stock Gains 20% in a Month: Buy Now or Hold Tight?
StockStory
1 Cash-Producing Stock on Our Buy List and 2 We Question
ATGE
StockStory
3 Reasons to Avoid ATGE and 1 Stock to Buy Instead
ATGE
Tipranks
Covista Inc. Rebrands and Unveils Healthcare Workforce Strategy
Zacks Investment Research
Adtalem Rebrands as Covista With Focus on Healthcare Workforce Needs
Adtalem Rebrands as Covista With Focus on Healthcare Workforce Needs
Zacks Investment Research
Zacks Industry Outlook Highlights Adtalem Global Education, Stride and American Public Education
Zacks Industry Outlook Highlights Adtalem Global Education, Stride and American Public Education
StockStory
The Top 5 Analyst Questions From Adtalem’s Q4 Earnings Call
ATGE
Zacks Investment Research
3 School Stocks Leveraging AI & Healthcare Demand Amid Headwinds
3 School Stocks Leveraging AI & Healthcare Demand Amid Headwinds
Motley Fool
This Education Stock Posted 34% EPS Growth, So Why Did One Fund Exit a $10.7 Million Stake?
StockStory
1 Small-Cap Stock to Keep an Eye On and 2 That Underwhelm
ATGE
Tipranks
Adtalem Global Education Earnings Call Shows Profitable Momentum
Tipranks
Barrington Reaffirms Their Buy Rating on Adtalem Global Education (ATGE)
Tipranks
Adtalem Global Education (ATGE) Receives a Buy from Jefferies
StockStory
Why Adtalem (ATGE) Stock Is Nosediving
ATGE
StockStory
ATGE Q4 Deep Dive: Enrollment Expansion and Digital Investments Drive Guidance Upside
ATGE
Motley Fool
Adtalem (ATGE) Q2 2026 Earnings Call Transcript
StockStory
Adtalem (NYSE:ATGE) Posts Better-Than-Expected Sales In Q4 CY2025
ATGE
StockStory
Adtalem (ATGE) Reports Q4: Everything You Need To Know Ahead Of Earnings
ATGE
StockStory
3 Overrated Stocks with Warning Signs
INTC
Tipranks
Barrington Keeps Their Buy Rating on Adtalem Global Education (ATGE)
StockStory
3 Consumer Stocks That Concern Us
AMCX
StockStory
YETI, Topgolf Callaway, Funko, Cushman & Wakefield, and Adtalem Shares Are Soaring, What You Need To Know
YETI
StockStory
1 of Wall Street’s Favorite Stock with Exciting Potential and 2 We Ignore
HZO
Motley Fool
This Education Stock Suddenly Lost a Investor Amid a Nearly 70% Surge
Motley Fool
Kestrel Bets on VTOL With $4.9 Million Buy

Profile

Adtalem Global Education Inc. is a healthcare educator principally in the United States. Adtalem Global Education Inc., formerly known as ADTELUM GBL EDU, is based in CHICAGO.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2026 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.